{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:11:58Z","timestamp":1778188318652,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.dmd.2026.100266","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:45:42Z","timestamp":1772815542000},"page":"100266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b]carbazole attenuates pressure overload cardiac hypertrophy by activating the CYP1A1\/19(S)-hydroxyeicosatetraenoic acid (HETE) and suppressing midchain-HETEs\/G protein coupled receptor 31 pathways"],"prefix":"10.1016","volume":"54","author":[{"given":"Ahmad H.","family":"Alammari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen M.","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadumo Ahmed","family":"Isse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshav","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-5707","authenticated-orcid":false,"given":"John R.","family":"Ussher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-0400","authenticated-orcid":false,"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dmd.2026.100266_bib1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","article-title":"Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets","volume":"89","author":"Tham","year":"2015","journal-title":"Arch Toxicol"},{"issue":"17","key":"10.1016\/j.dmd.2026.100266_bib3","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"13","key":"10.1016\/j.dmd.2026.100266_bib4","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/cvr\/cvz161","article-title":"Small animal models of heart failure","volume":"115","author":"Riehle","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.dmd.2026.100266_bib5","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00131.2017","article-title":"How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial","volume":"313","author":"Blaustein","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib6","article-title":"Aryl hydrocarbon receptor: a new player of pathogenesis and therapy in cardiovascular diseases","volume":"2018","author":"Yi","year":"2018","journal-title":"Biomed Res Int"},{"issue":"52","key":"10.1016\/j.dmd.2026.100266_bib7","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R800053200","article-title":"Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized Eicosanoids and AHR Biology","volume":"283","author":"Nebert","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib8","first-page":"1","article-title":"Gram-scale synthesis of FICZ, a photoreactive endogenous ligand of the aryl hydrocarbon receptor","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.dmd.2026.100266_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.123.001267","article-title":"6-Formylindolo[3,2-b]carbazole protects against angiotensin II-induced cellular hypertrophy through the induction of cytochrome P450 1A1 and its associated 19(S)-HETE metabolite in vitro","volume":"51","author":"Alammari","year":"2023","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2026.100266_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvn346","article-title":"Eicosanoid signalling pathways in the heart","volume":"82","author":"Jenkins","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.dmd.2026.100266_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1124\/dmd.118.082073","article-title":"S-Enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin ii-induced cardiac hypertrophy","volume":"46","author":"Shoieb","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2026.100266_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100266_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100077","article-title":"Sex-dependent alterations in cardiac cytochrome P450-mediated arachidonic acid metabolism in pressure overload\u2013induced cardiac hypertrophy in rats","volume":"53","author":"Gerges","year":"2025","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100266_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.dmd.2026.100266_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/can.2024.0148","article-title":"Effect of cannabistilbene I in attenuating angiotensin II-induced cardiac hypertrophy: insights into cytochrome P450s and arachidonic acid metabolites modulation","volume":"10","author":"Alammari","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.dmd.2026.100266_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cbi.2018.12.004","article-title":"Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states","volume":"299","author":"Shoieb","year":"2019","journal-title":"Chem Biol Interact"},{"issue":"19","key":"10.1016\/j.dmd.2026.100266_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.08.020","article-title":"19-Hydroxyeicosatetraenoic acid analogs: antagonism of 20-hydroxyeicosatetraenoic acid-induced vascular sensitization and hypertension","volume":"29","author":"Dakarapu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.dmd.2026.100266_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.taap.2015.10.003","article-title":"19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy","volume":"289","author":"Elkhatali","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.dmd.2026.100266_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.thromres.2016.06.031","article-title":"Relationship between metabolites of arachidonic acid and prognosis in patients with acute coronary syndrome","volume":"144","author":"Zu","year":"2016","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00204-015-1620-8","article-title":"The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy","volume":"90","author":"Maayah","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.dmd.2026.100266_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.642470","article-title":"The role of epoxyeicosatrienoic acids in cardiac remodeling","volume":"12","author":"Lai","year":"2021","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-025-02500-8","article-title":"The aryl hydrocarbon receptor: structure, signaling, physiology and pathology","volume":"11","author":"Coumoul","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.dmd.2026.100266_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115798","article-title":"The complex biology of aryl hydrocarbon receptor activation in cancer and beyond","volume":"216","author":"Opitz","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.dmd.2026.100266_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-protein-coupled receptors in heart disease","volume":"123","author":"Wang","year":"2018","journal-title":"Circ Res"},{"issue":"39","key":"10.1016\/j.dmd.2026.100266_bib26","doi-asserted-by":"crossref","first-page":"33832","DOI":"10.1074\/jbc.M110.216564","article-title":"Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.dmd.2026.100266_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2026.100266_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2022.106701","article-title":"The enantioselective separation and quantitation of the hydroxy-metabolites of arachidonic acid by liquid chromatography-tandem mass spectrometry","volume":"165","author":"Isse","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"32","key":"10.1016\/j.dmd.2026.100266_bib30","doi-asserted-by":"crossref","first-page":"15422","DOI":"10.1016\/S0021-9258(18)47743-5","article-title":"Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances","volume":"262","author":"Rannug","year":"1987","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.dmd.2026.100266_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1615\/CritRevEukarGeneExpr.v18.i3.20","article-title":"The aryl hydrocarbon receptor complex and the control of gene expression","volume":"18","author":"Beischlag","year":"2008","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"7","key":"10.1016\/j.dmd.2026.100266_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10408444.2018.1493086","article-title":"The tryptophan derivative 6-formylindolo[3,2-b]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation","volume":"48","author":"Rannug","year":"2018","journal-title":"Crit Rev Toxicol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100266_bib33","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.3390\/ijms23105403","article-title":"The aryl hydrocarbon receptor ligand FICZ improves left ventricular remodeling and cardiac function at the onset of pressure overload-induced heart failure in mice","volume":"23","author":"Tamayo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.dmd.2026.100266_bib34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.chemrestox.3c00002","article-title":"6-Formylindolo(3,2-b)carbazole dampens inflammation and reduces endotoxin-induced kidney injury via Nrf2 activation","volume":"36","author":"Dhulkifle","year":"2023","journal-title":"Chem Res Toxicol"},{"issue":"13","key":"10.1016\/j.dmd.2026.100266_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020502","article-title":"Activation of aryl hydrocarbon receptor by ITE improves cardiac function in mice after myocardial infarction","volume":"10","author":"Seong","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr218","article-title":"Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor","volume":"124","author":"Denison","year":"2011","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.dmd.2026.100266_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jss.2008.03.043","article-title":"Novel experimental model of pressure overload hypertrophy in rats","volume":"153","author":"Molina","year":"2009","journal-title":"J Surg Res"},{"issue":"118","key":"10.1016\/j.dmd.2026.100266_bib38","doi-asserted-by":"crossref","DOI":"10.3791\/54818","article-title":"A model of cardiac remodeling through constriction of the abdominal aorta in rats","volume":"2016","author":"Ku","year":"2016","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.dmd.2026.100266_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5830\/CVJA-2015-053","article-title":"Changes in cardiac structure and function in a modified rat model of myocardial hypertrophy","volume":"27","author":"Dai","year":"2016","journal-title":"Cardiovasc J Afr"},{"issue":"5","key":"10.1016\/j.dmd.2026.100266_bib40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.yjmcc.2005.02.012","article-title":"A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload","volume":"38","author":"Cantor","year":"2005","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.dmd.2026.100266_bib41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/FJC.0000000000001258","article-title":"Ameliorative role of fluconazole against abdominal aortic constriction-induced cardiac hypertrophy in rats","volume":"79","author":"Shoieb","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib42","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1038\/s41598-018-20613-9","article-title":"2-Methoxyestradiol protects against pressure overload-induced left ventricular hypertrophy","volume":"8","author":"Maayah","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.dmd.2026.100266_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvv101","article-title":"In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy","volume":"106","author":"Seymour","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.dmd.2026.100266_bib44","first-page":"H941","article-title":"Use of tibial length to quantify cardiac hypertrophy: application in the aging rat","volume":"243","author":"Yin","year":"1982","journal-title":"Am J Physiol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100266_bib45","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.biocel.2008.02.020","article-title":"Molecular regulation of cardiac hypertrophy","volume":"40","author":"Barry","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"10.1016\/j.dmd.2026.100266_bib46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/cvr\/cvy141","article-title":"A novel method for high precision aortic constriction that allows for generation of specific cardiac phenotypes in mice","volume":"114","author":"Melleby","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.dmd.2026.100266_bib47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/labinvest.2014.54","article-title":"RNA-sequencing analysis reveals new alterations in cardiomyocyte cytoskeletal genes in patients with heart failure","volume":"94","author":"Herrer","year":"2014","journal-title":"Lab Investig"},{"issue":"8","key":"10.1016\/j.dmd.2026.100266_bib48","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12489","article-title":"Diet-induced obesity promotes altered remodeling and exacerbated cardiac hypertrophy following pressure overload","volume":"3","author":"Holzem","year":"2015","journal-title":"Physiol Rep"},{"issue":"2","key":"10.1016\/j.dmd.2026.100266_bib49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/00220345231214195","article-title":"Intestinal translocation of live Porphyromonas gingivalis drives insulin resistance","volume":"103","author":"Niu","year":"2024","journal-title":"J Dent Res"},{"issue":"12","key":"10.1016\/j.dmd.2026.100266_bib50","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41366-019-0340-1","article-title":"Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity","volume":"43","author":"Lin","year":"2019","journal-title":"Int J Obesity"},{"issue":"13","key":"10.1016\/j.dmd.2026.100266_bib51","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1074\/jbc.M115.693655","article-title":"Aryl hydrocarbon receptor plays protective roles against high fat diet (HFD)-induced hepatic steatosis and the subsequent lipotoxicity via direct transcriptional regulation of Socs3 gene expression","volume":"291","author":"Wada","year":"2016","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1016\/j.dmd.2026.100266_bib52","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2026.100266_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpc.2016.03.011","article-title":"In vitro and in silico evaluation of transactivation potencies of avian AHR1 and AHR2 by endogenous ligands: implications for the physiological role of avian AHR2","volume":"187","author":"Kim","year":"2016","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100266_bib54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-2797(97)00111-7","article-title":"Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2- b]carbazole","volume":"110","author":"Wei","year":"1998","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","article-title":"Control of protein stability by post-translational modifications","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.dmd.2026.100266_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pharmtox.41.1.297","article-title":"Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1","volume":"41","author":"Murray","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.dmd.2026.100266_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/hh1901.097083","article-title":"Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHLH\/PAS transcription factor","volume":"89","author":"Kerzee","year":"2001","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.dmd.2026.100266_bib57","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1172\/JCI136621","article-title":"12(S)-HETE mediates diabetes-induced endothelial dysfunction by activating intracellular endothelial cell TRPV1","volume":"130","author":"Otto","year":"2020","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.dmd.2026.100266_bib58","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.3390\/cells10123347","article-title":"Metabolite G-protein coupled receptors in cardio-metabolic diseases","volume":"10","author":"Strassheim","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.dmd.2026.100266_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.997403","article-title":"Eicosanoids in inflammation in the blood and the vessel","volume":"13","author":"Yamaguchi","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100266_bib60","first-page":"e33","article-title":"Lipid receptor GPR31 (G-protein\u2013coupled receptor 31) regulates platelet reactivity and thrombosis without affecting hemostasis","volume":"41","author":"Doren L Van","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:45:53Z","timestamp":1778186753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0090955626000358"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100266","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b]carbazole attenuates pressure overload cardiac hypertrophy by activating the CYP1A1\/19(S)-hydroxyeicosatetraenoic acid (HETE) and suppressing midchain-HETEs\/G protein coupled receptor 31 pathways","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100266"}}